High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience

High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience

Aim. To assess the long-term results of high-dose chemotherapy following autologous hematopoietic stem cell transplantation (autoHSCT) for multiple myeloma (MM) in the real setting and influence of different factors on the results. Materials and methods. From 2006 till 2018 in Pirogovs Center wer...

Full description

Bibliographic Details
Main Authors: Nikita E. Mochkin, Vladislav O. Sarzhevskiy, Julia N. Dubinina, Elena G. Smirnova, Denis A. Fedorenko, Anna E. Bannikova, Dina S. Kolesnikova, Vladimir S. Bogatyrev, Anastasia A. Samoylova, Nikolay M. Faddeev, Vladimir Ya. Melnichenko
Format: Article
Language:Russian
Published: IP Habib O.N. 2020-07-01
Series:Современная онкология
Subjects:
multiple myeloma
high-dose chemotherapy
autologous hematopoietic stem cell transplantation
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/35195/23618

Internet

https://modernonco.orscience.ru/1815-1434/article/viewFile/35195/23618

Similar Items